A matched follow-up study design was used to test the hypothesis that pregnancy rates following assisted reproduction procedures do not differ between women with or without intramural or sub-serosal uterine leiomyomas. 
Introduction
Although data regarding the epidemiology of uterine leiomyomas are limited, leiomyomas appear to be the most common female pelvic tumour, occurring in as many as 30% of women Ͼ30 years of age (Zaloudek and Norris, 1987) . Although leiomyomas may be asymptomatic, they are associated with various symptoms, including menorrhagia, pelvic pain, and urinary symptoms. However, it is unclear whether or not leiomyomas are associated with infertility or affect the outcome of assisted reproduction cycles. Therefore, it is difficult, at best, to counsel patients undergoing assisted reproduction
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© European Society for Human Reproduction and Embryology regarding the effects of a uterine leiomyoma(s) on the success of an anticipated cycle.
There is some evidence to suggest an association between leiomyomas and reproductive dysfunction. In a retrospective study of women with uterine leiomyomas who presented in labour, 26/60 (43%) had at least a 2 year history of infertility (Hasan et al., 1990) , suggesting an association between infertility and uterine leiomyomas. Furthermore, in several uncontrolled surgical trials, restoration of fertility after myomectomy in a cohort of women with a history of infertility has been reported with gross pregnancy rates ranging from 44 to 62%, with as many as 80% of the post-myomectomy pregnancies occurring in the first year after surgery (Babaknia et al., 1978; Berkeley et al., 1983; Rosenfeld, 1986; Gehlbach et al., 1993; Dubuisson et al., 1996) . However, none of these studies included a control group for comparison, nor have any longterm longitudinal studies been performed in which leiomyomas were observed without intervention to determine the impact of leiomyomas on fertility. Therefore, it is still unclear whether one should advocate myomectomy for infertility or if leiomyomas are even associated with infertility.
In addition to the possible adverse effects of uterine leiomyomas on female fecundity, some evidence suggests that leiomyomas are associated with an increased risk of spontaneous abortion (Matsunaga and Shiota, 1980; Rosati et al., 1989) . In these studies, it appears that the risk of spontaneous abortion may depend upon the size and position of the leiomyoma. More specifically, larger leiomyomas tended to have a greater impact on the risk of pregnancy loss as compared to smaller leiomyomas. Myomectomy has been reported to decrease the risk of spontaneous abortion. In a review of 1941 cases, a 50% reduction in the spontaneous abortion rate was reported after myomectomy (Buttram and Reiter, 1981) . Here again, there was no control group for comparison so it is difficult to assess the true impact of myomectomy on the spontaneous abortion rate.
The purpose of this study was to test the hypothesis that pregnancy rates do not differ between women with or without intramural or subserosal uterine leiomyomas. The results of assisted reproduction cycles, in-vitro fertilization (IVF)-embryo transfer and zygote intra-Fallopian transfer (ZIFT), performed in women with and without leiomyomas were used to assess the effect, if any, of uterine leiomyomas on reproductive success, defined as a clinical pregnancy. To date, the only study to use the results from assisted reproduction cycles to assess the effect of leiomyomas on pregnancy rates found that leiomyomas were associated with a decreased pregnancy rate only when accompanied by an intracavitary abnormality (Farhi et al., 1995) . As it has been our policy to remove all submucosal leiomyomas before allowing a patient to proceed with an assisted reproduction cycle, the impact of submucosal leiomyomas on reproductive success could not be evaluated in this study. Conversely, myomectomy was not recommended for patients who were considering an assisted reproduction cycle and were found to have one or more small (Ͻ6 cm) intramural or subserosal leiomyomas if a hysterosalpingogram had revealed a normal uterine cavity. This study evaluated the effect of those leiomyomas on the success of assisted reproduction cycles.
Materials and methods

Study population
Women eligible for participation in the study were patients undergoing either an IVF-embryo transfer or ZIFT cycle through the University of Iowa Assisted Reproduction Program between January 1, 1993 and June 30, 1995. Prior to their assisted reproduction cycle, each patient underwent a complete history and physical examination by one of the physicians performing IVF procedures at the University, and signed a consent form approved by the University of Iowa Institutional Review Board which stated that data from their assisted reproduction cycle would be recorded and placed in an assisted reproduction data base for analysis. Patients undergoing assisted reproduction cycles involving oocyte donation were excluded from the study, as were women who were undergoing transfer of cryopreserved embryos. Regardless of the number of IVF-embryo transfer or ZIFT cycles any individual underwent during the study interval, only the first cycle from any individual couple was included in the study. Although the assisted reproduction data base was used to identify subjects, individual patient records were reviewed for all study participants to verify the accuracy of the data contained within the data base. All patients with leiomyomas who met the entry criteria were included in the study.
Treatment protocol
Ovarian stimulation was achieved using a medication protocol similar to the one previously described (Van Voorhis et al., 1995) . Briefly, the gonadotrophin-releasing hormone agonist (GnRHa) leuprolide acetate (1 mg SC Lupron; TAP Pharmaceuticals, North Chicago, IL, USA) was administered from day 23 of the cycle preceding stimulation until the day of human chorionic gonadotrophin (HCG) administration. Follicular stimulation was initiated with three ampoules of follicle stimulating hormone (FSH) (Metrodin; Serono Laboratories, Inc., Randolph, MA, USA) for 3 days. Subsequent stimulation was achieved using a combination of FSH and HMG (Humegon; Organon, West Orange, NJ, USA) with doses determined by ovarian response as measured by serum oestradiol levels and ultrasound evaluation. HCG (10 000 U Pregnyl; Organon) was administered when at least two follicles were ജ18 mm in maximal diameter with a serum oestradiol concentration of ജ500 pg/ml (conversion factor to SI units, 3.671). The double-layer endometrial stripe thickness was measured on the day of HCG administration.
All oocyte retrievals were performed using a transvaginal ultrasound-guided technique. Fertilization of recovered oocytes was assessed 14-18 h after insemination. Pronuclear stage embryos were assigned quality grades ranging from zero (best) to three (worst) as previously described (Hammitt et al., 1993) . Similarly, cleavagestaged embryos were assigned quality grades on the second day after oocyte retrieval using a zero to three scoring system based on the scale outlined by Fishel et al. (1988) .
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When additional embryos were available for cryopreservation, the highest grade embryos were selected for 'fresh' embryo transfer in all cases and the lower quality grade embryos were cryopreserved. All uterine embryo transfers were performed 2 days after oocyte retrieval by transcervically transferring cleavage-staged embryos to the uterine fundus using a Tefcat catheter (Cook, Spencer, IN, USA). Tubal embryo transfers were performed on the day after oocyte retrieval via laparoscopy, with embryos placed in the mid-ampullary portion of the Fallopian tube using a 5 French GIFT catheter (Cook, Melbourne, Victoria, Australia). All uterine and Fallopian tube embryo transfers were performed by one of three of the authors (D.W.S., C.H.S. and B.V.V.). Assisted reproduction cycles were performed in an identical manner, independent of the presence or absence of uterine leiomyomas. All patients were evaluated at a return clinic visit 14-16 days after embryo transfer, at which time a pregnancy test was performed. Patients with positive pregnancies had repeat quantitative serum HCG levels drawn in 48 h. Women with appropriately rising HCG titres underwent transvaginal ultrasonography 10-12 days after their initial positive pregnancy test. A clinical pregnancy was defined by the presence of one or more gestational sacs on transvaginal ultrasound. Implantation rates were calculated for both cases and controls by dividing the total number of gestational sacs per group by the total number of embryos transferred per group. All pregnancies were followed to delivery. Pregnancy and delivery rates were calculated per oocyte retrieval.
Uterine evaluation
Each subject underwent a hysterosalpingogram within 12 months of their assisted reproduction procedure. Both the dictated report and roentgenogram films of each study participant were reviewed by one of the authors. All patients underwent a baseline pelvic ultrasound in the luteal phase of the menstrual cycle in which pituitary down regulation was initiated, using a General Electric RT 3600 (Milwaukee, WI, USA) with a 5 MHz vaginal transducer. Initially the uterus was evaluated using a sweeping motion during which the full length of the uterus was scanned in both a sagittal and coronal view. If one or more leiomyomas were identified during the uterine sweep, the location, size and total number of leiomyomas was recorded. The location of the leiomyomas was divided into the following categories: fundal, lower uterine segment and cervical. Each leiomyoma was measured in two dimensions in either the coronal or sagittal view, making sure that the largest diameter of the leiomyoma was included in the measurement. Next, the endometrial lining was evaluated. Abnormalities within the endometrial cavity were recorded. Subjects were excluded from the study if a uterine filling defect was detected on hysterosalpingogram or if an intrauterine lesion was noted during the baseline pelvic ultrasound. Women who had undergone surgery for removal of a leiomyoma, endometrial polyp, or uterine septum were excluded from the study.
Study design
To evaluate the effect of leiomyomas on the efficacy of assisted reproduction cycles, a matched follow-up study design was used (Rothman, 1986) . In a matched follow-up study, cases and controls are defined by their exposure status (e.g. the presence or absence of a leiomyoma) and followed to determine their outcome status (e.g. pregnant or not pregnant). As compared to a case-control study, matched follow-up studies are better at excluding confounding variables, as cases are matched to controls based on independent variables that are known to affect the main outcome event(s). Furthermore, a matched follow-up study design allows one to calculate an estimate of relative risk as opposed to an estimate of the odds ratio that is generated by a case-control study design. Therefore, as compared to case-control studies, matched follow-up studies yield a more precise estimate of the true effect of exposure on a given outcome. Women with uterine leiomyomas (cases) were matched one-to-one with the next consecutive patient without a uterine leiomyoma (controls). Cases were matched to the next consecutive control to reduce the effect of fluctuations in pregnancy rates that may occur over time that are not a function of patient selection. Each IVFembryo transfer or ZIFT cycle was considered an independent event. Cases and controls were matched according to maternal age (Ͻ35; ജ35 years), number of embryos transferred (Ͻ3; ജ3), embryo grade (mean Ͻ1.0; mean ജ1.0), and route of embryo transfer (uterine or Fallopian). Subjects were not matched based on their primary or secondary infertility (i.e. gravidity and parity). However, the distribution of the infertility was analysed to determine if differences existed between cases and controls. Similarly, the mean gravidity and parity of the two study groups were analysed. The primary outcome event of interest was clinical pregnancy. The secondary outcome events of interest were delivery, embryo implantation and spontaneous abortion.
We used a 20% absolute percentage difference in clinical pregnancy rates (e.g. 40 versus 20%) as the effect size for our power calculations. This determination was made after review of our data base revealed a similar impact from variables with an established adverse effect on clinical pregnancy rates. More specifically, the effect of age on assisted reproduction success was evaluated. This analysis revealed a 20% difference in combined IVF-embryo transfer and ZIFT clinical pregnancy rates between women who were Ͻ40 and ജ40 years old on the day of oocyte retrieval. Using an effect size of 20%, an α of 0.05, a β of 0.20 (power ϭ 80%) and matching one case to one control, the total sample size was determined to be 180 (i.e. 90 cases and 90 controls).
The relative risk (RR) of pregnancy and delivery from assisted reproduction associated with uterine leiomyomas was estimated using the Mantel-Haenszel technique (Rothman, 1986) , as programmed in PC-SAS (SAS Institute Inc, 1988) . This technique also provides 95% confidence intervals (CI) for the Mantel-Haenszel estimators. A χ 2 test was used to assess differences in implantation and spontaneous abortion rates. An unpaired t-test was used to assess differences in 194 continuous variables between cases and controls including age, gravidity, parity, number of embryos transferred, embryo grade and endometrial thickness on the day of HCG administration.
Results
Of the 488 cycles of IVF-embryo transfer and ZIFT performed between January 1, 1993 and June 30, 1995, 91 cases met the entry criteria and were matched to a control. The overall clinical pregnancy and delivery rates for IVF-embryo transfer during the interval of the study were 29.0 (82/283) and 26.1% (74/283) respectively. The overall clinical pregnancy and delivery rates for ZIFT during the interval of the study were 51.2 (105/205) and 43.4% (89/205) respectively. The implantation rate for all IVF-embryo transfer and ZIFT procedures performed during the interval of the study was 17.6% (310/1757). The mean Ϯ SD age on the day of retrieval of the women undergoing IVF-embryo transfer and ZIFT during the study interval was 36.6 Ϯ 3.1 years. The characteristics of the stratification subgroups into which cases and controls were matched are shown in Table I . The number of cycles listed is the total number of attempts for both cases and controls. There were 49 tubal and 42 uterine embryo transfers in each group.
Of the 91 assisted reproduction cycles performed in the leiomyoma group, there were 34 clinical pregnancies (37.4%) and 30 deliveries (33.0%). Of the 91 assisted reproduction cycles in the control group, there were 48 clinical pregnancies (52.7%) and 44 deliveries (48.4%). The Mantel-Haenszel estimate of RR indicated that the presence of a uterine leiomyoma significantly reduced the likelihood of pregnancy (52.7 versus 37.4%) and delivery (48.4 versus 33.0%) from assisted reproduction (RR ϭ 0.71; 95% CI ϭ 0.51-0.98 and RR ϭ 0.68; 95% CI ϭ 0.47-0.98 respectively). A comparison of pregnancy and delivery rates between cases and controls is shown in Figure 1 . There were 13 twin gestations and two triplet gestations in the non-myoma group and 10 twin gestations and one triplet gestation in the leiomyoma group. The implantation rates were 46/334 (13.8%) in the leiomyoma group and 65/330 (19.7%) in the control group, and were significantly different (χ 2 ϭ 4.18, P Ͻ 0.05). The difference in spontaneous abortion rates between cases 4/34 (11.8%) and controls 4/48 (8.3%) was not significant (χ 2 ϭ 0.22, P ϭ 0.64). The distribution of the primary infertility diagnoses was similar in both cases and controls as illustrated in Table II . Although some subjects had more than one diagnosis, including leiomyomata, only the major infertility diagnosis is listed. There were no differences between cases and controls with respect to age, gravidity, parity, number of embryos transferred, embryo grade or thickness of the endometrial stripe on the day of HCG administration, as shown in Table III .
The mean of the largest and smallest leiomyoma diameter 195 was 28.7 mm (range, 10-54 mm) and 19.7 mm (range, 8-28 mm) respectively. A total of 164 leiomyomas was identified in the 91 cases, and the mean number of leiomyomas per patient was 1.8 Ϯ 0.8. Most of the leiomyomas identified (93.3%) were located in the uterine fundus. The remaining 11 leiomyomas were located in the lower uterine segment. There were no cervical leiomyomas. The majority of the leiomyomas were classified as intramural lesions (94.5%), while only nine (5.5%) were classified as subserosal lesions.
Discussion
In this matched follow-up study, we found that women with leiomyomas who are undergoing either IVF-embryo transfer or ZIFT have acceptable pregnancy rates. The clinical pregnancy rate found in the leiomyoma group was 37.4%. However, when the pregnancy rate of the women with leiomyomas was compared to a control group without leiomyomas, who were matched with regard to age, number of embryos transferred, embryo quality and the route of embryo transfer, women with leiomyomas were found to have a significantly reduced chance for pregnancy. Without an appropriate control group for comparison, we might have concluded that leiomyomas had no impact on the efficacy of assisted reproduction cycles. These findings highlight the importance of using controls for comparison when evaluating the effect of a given disease process on the efficacy of assisted reproduction procedures. Although cases and controls were matched with regard to several prognostic factors, these two groups were not matched with regard to gravida, parity or infertility diagnosis. Our search of the literature revealed no data which clearly address the influence of gravidity or parity on subsequent IVF success. Nevertheless, as shown in Table III , the differences in both gravidity (0.9 versus 1.4) and parity (0.5 versus 0.7) between cases and controls were small and not significant. Adding the infertility diagnosis as a fifth prognostic variable would have reduced our sample size significantly and likewise limited the power of the study. Furthermore, there were no significant differences with regard to the type of infertility between cases and controls, as shown in Table II .
The pregnancy rate of the control group (52.7%) was significantly higher than the pregnancy rate for all women undergoing IVF-embryo transfer and ZIFT during the study interval (38.3%). There are several possible explanations for this occurrence. First, the mean age of the control group (35.9 Ϯ 3.4) was less than the mean age of the entire population of women undergoing assisted reproduction during the study interval (36.8 Ϯ 3.1). Second, the percentage of couples in the control group with male factor infertility (23.1%) was lower than the percentage of couples with male factor infertility undergoing IVF-embryo transfer and ZIFT during the study interval (31.1%). Third, the mean number of embryos transferred in the control group (3.6 Ϯ 1.2) was higher than the mean number of embryos transferred during the study interval (3.2 Ϯ 1.7). Recalling that these and other prognostic factors from each case were used to select the controls, without prior knowledge of the outcomes of interest, we believe that the control group is not biased towards a more favourable outcome as compared to the leiomyoma group. Instead, the characteristics of the cases lead to selection of a control group with a more favourable prognosis as compared to other couples undergoing assisted reproduction cycles during the same time interval.
Our finding that leiomyomas have a negative effect on fertility is supported by studies of patients undergoing myomectomy. Most myomectomy series report an improved pregnancy rate after surgery, but these data (Babaknia et al., 1978; Berkeley et al., 1983; Rosenfeld, 1986; Gehlbach et al., 1993) are the product of uncontrolled trials and importantly, do not contain completely consistent findings. More specifically, in the reports of women undergoing myomectomy strictly for the indication of infertility, the postoperative cumulative pregnancy rates range from 16% (Berkeley et al., 1983) to 57% (Gehlbach et al., 1993) . Given this wide range of 'success' and the absence of a control group for comparison, it is difficult to determine the true impact of surgical therapy in the treatment of leiomyoma-associated infertility. On the other hand, even if one were convinced that women with otherwise unexplained infertility did not experience an improvement in their infertility after myomectomy, one would not necessarily conclude that there is no association between leiomyomas and infertility. Instead, one might merely conclude that myomectomy is ineffective in the treatment of leiomyoma-associated infertility.
Previous data have suggested that leiomyomas may increase the risk of spontaneous abortion (Matsunaga and Shiota, 1980) . Furthermore, myomectomy has been reported to reduce the rate of spontaneous abortion (Buttram and Reiter, 1981) . We did not find an association between leiomyomas and spontaneous abortion. The spontaneous abortion rates for cases and controls were 4/34 (11.8%) and 4/48 (8.3%) respectively. This finding is consistent with several possibilities. First, leiomyomas may not be associated with an increased risk of spontaneous abortion. Second, this may reflect an inadequate power of our study to detect a small difference in spontaneous abortion rates between women with and without a leiomyoma. Furthermore, women with submucosal leiomyomas and those with uterine filling defects were excluded from our study, and it is possible that submucosal leiomyomas may have a greater impact on spontaneous abortion than either intramural or subserosal leiomyomas that do not distort the endometrial cavity. Lastly, previous data suggest that larger leiomyomas may have a greater effect on the risk of pregnancy loss as compared to smaller leiomyomas (Rosati et al., 1989) . The average size of a leiomyoma in our study was small (28.7 ϫ19.7 mm). Therefore, if a relationship between leiomyomas and spontaneous abortion does exist, it may only occur in subjects whose leiomyomas are either large (i.e. Ͼ5 cm) or located within the endometrial cavity.
The mechanism(s) by which leiomyomas may cause infertility is unclear. Some hypotheses focus on the effects of leiomyoma on sperm transport due to changes in uterine contour (Hunt and Wallach, 1974) or uterine contractility (Coutinho and Maia, 1971; Iosif and Akerlund, 1983) . This study evaluated embryo transfer cycles and therefore, we did not assess the effects of leiomyomas on sperm transport. Instead, it appears that the mechanism whereby leiomyomas 196 impaired fertility in our study population was by interfering with implantation. The implantation rate of the leiomyoma group (13.8%) was significantly lower than the matched control group (19.7%).
Numerous changes in the endometrium have been associated with leiomyomas. Included are endometrial atrophy, hyperplasia, inflammation, and vascular alterations (Deligdish and Loewenthal, 1970; Farrer-Brown et al., 1971; Forssman, 1976) . As women undergoing ovarian stimulation rarely experience endometrial atrophy and as the endometrial thickness of the two study groups was similar, it is unlikely that either endometrial atrophy or hyperplasia played a significant role in the decline in pregnancy rates observed in women with leiomyomas. We cannot exclude inflammation or vascular alterations as possible causes for the relationship between leiomyomas and a reduced efficacy of assisted reproduction cycles. Other causes of implantation failure, including alterations in the production of adhesion molecules, may also be linked to the presence of uterine leiomyomas. No matter what mechanism(s) alter embryo implantation in women with leiomyomas, our data would suggest that the effect may be age dependent. As one looks closely at Table I , it is evident that a significant proportion of the effect of leiomyomas on the success of assisted reproduction cycles occurred in women under age 35. Further study will be required to determine the specific mechanism(s) by which leiomyomas impair implantation.
Leiomyomas are a common gynaecological problem that can be identified by non-surgical means and, based on the results of this study, appear to reduce the efficacy of assisted reproduction procedures. Although these data suggest that there is an association between leiomyomas and infertility, the effectiveness of myomectomy on infertility was not evaluated in this study and one cannot advocate myomectomy solely for the indication of infertility based on the findings in this study. The mechanism(s) by which leiomyomas reduce the efficacy of assisted reproduction procedures can only be determined by future investigation. Further investigation will be required to assess the impact of the location, size and number of leiomyomas on the success of assisted reproduction procedures.
